Sign in

CIK 0001000694 · Large accelerated filer

NOVAVAX INC

Sign in to watch
Ticker
NVAX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
222816046
Phone
240-268-2000
Business address
21 FIRSTFIELD RD, GAITHERSBURG, MD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-12-31 YOUNG JAMES F Director Sale −5,400 $8.00 $43K 51,760
2024-12-24 YOUNG JAMES F Director Sale −4,600 $8.48 $39K 57,160
2024-12-13 King Rachel K. Director Sale −4,150 $9.02 $37K 14,770
2024-06-21 YOUNG JAMES F Director Sale −7,500 $14.09 $106K 61,760
2024-06-18 YOUNG JAMES F Director Sale −6,393 $13.62 $87K 70,367
2024-06-18 YOUNG JAMES F Director Sale −1,107 $14.28 $16K 69,260
2024-06-17 Dubovsky Filip President, R&D Sale −12,500 $14.46 $181K 68,017
2024-06-17 Dubovsky Filip President, R&D Sale −1,404 $14.54 $20K 66,613
2024-05-14 Dubovsky Filip President, R&D Sale −47,312 $13.90 $658K 38,953

Page 1 of 1 · 9 trades